GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
    • Scientific Advisory Board
    • Reports
      • GHTM
  • Research
    • Cross-cutting issues
      • Genomic Surveillance and Population Mobility
      • Antimicrobial Resistance and Drug Discovery
      • Host–Pathogen Interactions
      • Information for Health Development
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • PRIME – Pathogen resistance, infection and molecular epidemiology
      • VBD – Vector borne diseases
      • CTM – Clinical tropical medicine
    • Research in numbers
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
    • BIOHUB & Available Software
    • BIOTROP Biobank
    • VIASEF & Insectaries
  • Networks & Partnerships
Home / Publications / Sleeping sickness: towards elimination?

Sleeping sickness: towards elimination?

  • Authors: Atouguia J, Seixas J
  • Publication Year: 2015
  • Journal: Anais do Instituto de Higiene e Medicina Tropical
  • Link: http://ihmtweb.ihmt.unl.pt/PublicacoesFB/Anais/Anais2015/index.html#43/z%20

Sleeping Sickness (SS) is being controlled in most African countries after the epidemic that started in the 1990’s.WHO had a major role in building awareness and implementing solutions that covered capacity building, diagnosis optimization, drug availability and distribution and vector control measures.Although much remains to be done specially in countries with civil instability, the Atlas of Human African Trypanosomiasis, aWHO project now available as a tool for SS surveillance in Africa, should help reach elimination of the Gambiense form of this disease in the next 5 to 10 years. Learning from colonial SS control programs successfully established in the middle of the last century is important in the present situation; evaluating the social and anthropological components of the disease is critical for securing long term eradication.The example of Angola, where formerly epidemic SS has reached eradication stage should be studied and attentively followed up. Although SS treatment still relies on old and toxic drugs, a better combination therapy (NECT) for the neurologic stage of Gambiense disease is now available. A new oral drug able to treat both stages of the disease should be ready to be rolled- out in the coming years.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Pinterest (Opens in new window) Pinterest
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Print (Opens in new window) Print

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Funding

UID/04413/2025 - DOI: 10.54499/UID/04413/2025

UID/PRR/04413/2025 - DOI: 10.54499/UID/PRR/04413/2025

UID/PRR2/04413/2025 - DOI: 10.54499/UID/PRR2/04413/2025

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2026 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.